Sudden Death Trajectories in HFpEF, HFmrEF - Scorecard - MDSpire

Sudden Death Trajectories in HFpEF, HFmrEF

Clinical changes before death overlap across outcomes

  • By

  • Kathryn Wighton

  • March 31, 2026

  • 4 min

Share

Clinical Scorecard: Sudden Death Trajectories in HFpEF, HFmrEF

At a Glance

CategoryDetail
ConditionHeart Failure with Preserved Ejection Fraction (HFpEF) and Mildly Reduced Ejection Fraction (HFmrEF)
Key MechanismsWorsening functional status, symptom burden, and natriuretic peptide levels precede sudden death.
Target PopulationPatients with symptomatic heart failure and left ventricular ejection fraction of 40% or greater.
Care SettingCardiology clinics and hospitals.

Key Highlights

  • Sudden death accounts for 25% to 30% of deaths in HFpEF.
  • Modest worsening in NYHA class and KCCQ-TSS observed before sudden death.
  • NT-proBNP levels increased significantly in patients who experienced sudden death.
  • Current guidelines do not recommend implantable cardioverter-defibrillators for primary prevention.
  • Nonspecific nature of changes limits immediate clinical actionability.

Guideline-Based Recommendations

Diagnosis

  • Monitor NYHA functional class, KCCQ-TSS, and NT-proBNP levels.

Management

  • No specific preventive strategies for sudden death recommended due to risk stratification limitations.

Monitoring & Follow-up

  • Regular assessment of functional status and natriuretic peptide levels.

Risks

  • Increased risk of sudden death associated with worsening functional class and declining health status.

Patient & Prescribing Data

Patients with symptomatic heart failure and ejection fraction ≥ 40%.

Focus on overall health status and functional improvement rather than specific sudden death prevention.

Clinical Best Practices

  • Assess functional status and symptom burden regularly.
  • Consider overall risk rather than specific sudden death risk for treatment decisions.
  • Utilize patient-reported outcomes in monitoring.

Related Resources & Content

Original Source(s)

Sudden Death Trajectories in HFpEF, HFmrEF

  • by Kathryn Wighton

  • March 31, 2026

Related Content

Cell Aging May Predict Future Disease

Plasma proteomic models of more than 40 cell types were associated with incident Alzheimer's disease, amyotrophic lateral sclerosis, cancer,  and mortality across three large cohorts.

CGM Linked to More Time in Range

In a randomized crossover trial of insulin-treated patients receiving hemodialysis, real-time continuous glucose monitoring did not improve the primary hypoglycemia outcome but increased time in range and reduced time above range vs capillary testing.

Which Exercise Best Lowers Ambulatory BP?

‘Combined training and high-intensity interval training were also associated with reductions in 24-hour ambulatory blood pressure’